Analytical performance of the Synchron LX®20 Pro, BN™II and IMMAGE® high sensitivity C-reactive protein assays and concordance in cardiovascular risk stratification

Clinica Chimica Acta

Volumn 347, Issue 1-2, 2004, Pages 71-79

  McWhorter, Valerie C ^a   Ford, Lynne C ^a   Butch, Anthony W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Cardiovascular disease; Immunoassay; Inflammation; Nephelometry; Turbidimetry

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; AUTOANALYZER; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; EVALUATION; HEMOLYSIS; HYPERLIPIDEMIA; MEASUREMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SERUM;

ANIMALS; BILIRUBIN; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; HEMOGLOBINS; HUMANS; IMMUNOASSAY; MICE; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 4143142067     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.03.034     Document Type: Article

References (19)

1. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 279:1998;1477-1482
2. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 321:2000;199-204
3. Rifai N., Buring J.E., Lee I.M., Manson J.E., Ridker P.M. Is C-reactive protein specific for vascular disease in women? Ann. Intern. Med. 136:2002;529-533
4. Rifai N., Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47:2001;403-411
5. Ridker P.M., Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J. Investig. Med. 46:1998;391-395
6. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347:2002;1557-1565
7. Albert C.M., Ma J., Rifai N., Stampfer M.J., Ridker P.M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 105:2002;2595-2599
8. Ridker P.F., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979
9. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 97:1998;425-428
10. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:1999;2136-2141
11. Rothkrantz-Kos S., Bekers O., Gubbels A., Drent M., Schmitz M., van Dieijen-Visser M.P. Evaluation of two new high-sensitivity methods for C-reactive protein. Ann. Clin. Biochem. 40:2003;398-405
12. Roberts W.L., Sedrick R., Moulton L., Spencer A., Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin. Chem. 46:2000;461-468
13. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O. III, Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107:2003;499-511
14. Macy E.M., Hayes T.E., Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43:1997;52-58
15. Sung H.J., Kim J.H., Park R., Lee K.R., Kwon O.H. Evaluation of Denka-Seiken turbidimetric high-sensitivity C-reactive protein assay. Clin. Chem. Lab. Med. 40:2002;840-845
16. Ledue T.B., Weiner D.L., Sipe J.D., Poulin S.E., Collins M.F., Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann. Clin. Biochem. 35:1998;745-753
17. Kimberly M.M., Vesper H.W., Caudill S.P., Cooper G.R., Rifai N., Dati F., et al. Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. Clin. Chem. 49:2004;611-616
18. Johnson A., Sampson E., Blirup-Jensen S., Scvendsen P. Recommendations for the selection and use of protocols for assignment of values to reference materials. Eur. J. Clin. Chem. Clin. Biochem. 34:1996;279-285
19. Ledue T.B., Rifai N. High sensitivity immunoassay for C-reactive protein: promises and pitfalls. Clin. Chem. Lab. Med. 39:2001;1171-1176